India has invited fresh applications under its production-linked incentive scheme for medical devices, with about ₹2,700 crore available and the programme extended through 2035–36.
The revised scheme removes the minimum sales threshold for claiming incentives and reduces the minimum investment requirement. Applicants will have three years to establish manufacturing capacity.
Critical components move to the centre
The application window covers medical consumables, disposables and implants; critical components; high-end devices at an early stage of domestic production; and high-end equipment currently assembled in India.
Indicative average incentive rates taper at about 5% for consumables and implants, 9% for critical components and nascent high-end devices, and 6% for high-end equipment that is mainly assembled domestically.
The first phase has supported domestic production of more than 60 devices and components, including MRI systems, X-ray tubes and detectors, CT scanners, linear accelerators, cardiac implants and dialysers. The government reports cumulative production above ₹16,000 crore.
Deeper manufacturing is the real test
The policy now emphasises value-chain integration rather than final assembly alone. Components such as ultrasound probes, imaging detectors and advanced diagnostic sub-systems can carry more technology and supplier-development value than assembly of imported kits.
Applicants may submit multiple proposals across target segments, and the portal is expected to open within ten days. A continuously open application window should reduce the risk that a viable project misses a single short deadline.
The next checkpoints are the number and quality of applications, the share directed toward component production, and whether projects reach commercial scale within the three-year setup window.
Source: Department of Pharmaceuticals via PIB, 10 November 2026.
This article is journalism and commentary. It is not a recommendation to buy or sell any security, and it is not professional advice. Read the full disclaimer.
